High doses of dextromethorphan induced shock and convulsions in a 19-year-old female: A case report.

Case report Dextromethorphan Drug overdose Shock Symptom Treatment

Journal

World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806

Informations de publication

Date de publication:
06 Jun 2023
Historique:
received: 24 02 2023
revised: 14 04 2023
accepted: 04 05 2023
medline: 29 6 2023
pubmed: 29 6 2023
entrez: 29 6 2023
Statut: ppublish

Résumé

Dextromethorphan is a prevalent antitussive agent that can be easily obtained as an over-the-counter medication. There has been a growing number of reported cases of toxicity in recent years. Generally, there are numerous instances of mild symptoms, with only a limited number of reports of severe cases necessitating intensive care. We presented the case of a female who ingested 111 tablets of dextromethorphan, leading to shock and convulsions and requiring intensive care that ultimately saved her life. A 19-year-old female was admitted to our hospital We report the first case of shock caused by an overdose of dextromethorphan.

Sections du résumé

BACKGROUND BACKGROUND
Dextromethorphan is a prevalent antitussive agent that can be easily obtained as an over-the-counter medication. There has been a growing number of reported cases of toxicity in recent years. Generally, there are numerous instances of mild symptoms, with only a limited number of reports of severe cases necessitating intensive care. We presented the case of a female who ingested 111 tablets of dextromethorphan, leading to shock and convulsions and requiring intensive care that ultimately saved her life.
CASE SUMMARY METHODS
A 19-year-old female was admitted to our hospital
CONCLUSION CONCLUSIONS
We report the first case of shock caused by an overdose of dextromethorphan.

Identifiants

pubmed: 37383112
doi: 10.12998/wjcc.v11.i16.3870
pmc: PMC10294160
doi:

Types de publication

Case Reports

Langues

eng

Pagination

3870-3876

Informations de copyright

©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Références

J Addict Med. 2013 Mar-Apr;7(2):143-4
pubmed: 23388679
CJEM. 2011 Jan;13(1):53-6
pubmed: 21324299
Clin Neuropharmacol. 2020 Sep/Oct;43(5):127-133
pubmed: 32947422
Curr Opin Pediatr. 2006 Apr;18(2):184-8
pubmed: 16601501
Br J Clin Pharmacol. 2010 Dec;70(6):794-8
pubmed: 21175434
Drug Metab Rev. 2020 May;52(2):258-282
pubmed: 32393072
Pediatr Emerg Care. 2004 Dec;20(12):858-63
pubmed: 15572980
J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):e20-5; quiz e26-7
pubmed: 19289333
PLoS One. 2014 Feb 12;9(2):e82452
pubmed: 24533044
Mil Med. 2020 Aug 14;185(7-8):e926-e929
pubmed: 32236409
Arch Pediatr Adolesc Med. 2006 Dec;160(12):1217-22
pubmed: 17146018
J Med Assoc Thai. 2005 Nov;88 Suppl 8:S242-5
pubmed: 16856446
Pediatr Emerg Care. 2011 Mar;27(3):210-1
pubmed: 21378523
Subst Abuse Rehabil. 2013 Nov 06;4:75-82
pubmed: 24648790
Ann N Y Acad Sci. 2004 Oct;1025:458-64
pubmed: 15542749
CMAJ. 2014 Nov 4;186(16):E631
pubmed: 25135924
JAAPA. 2018 Aug;31(8):1-5
pubmed: 30048361
Acta Neurol Scand. 1996 Feb-Mar;93(2-3):94-8
pubmed: 8741125
Adolesc Med State Art Rev. 2015 Dec;26(3):570-88
pubmed: 27282013
Pharmacol Ther. 2016 Aug;164:170-82
pubmed: 27139517
Dtsch Arztebl Int. 2010 Jul;107(30):537-40
pubmed: 20737060
BMJ Case Rep. 2017 Aug 7;2017:
pubmed: 28784915
J Forensic Sci. 2012 Sep;57(5):1388-94
pubmed: 22537430
Perspect Public Health. 2014 Nov;134(6):309
pubmed: 25485349
Psychopharmacology (Berl). 2012 Sep;223(1):1-15
pubmed: 22526529
Am J Addict. 2016 Aug;25(5):374-7
pubmed: 27288091
Pharmacol Biochem Behav. 2021 Apr;203:173129
pubmed: 33515586
CMAJ Open. 2015 Nov 09;3(4):E387-94
pubmed: 27570758
Am J Emerg Med. 2022 Nov;61:233.e1-233.e2
pubmed: 35989201
Ann N Y Acad Sci. 2008 Oct;1139:402-11
pubmed: 18991887
J Addict Dis. 2011 Jul-Sep;30(3):243-7
pubmed: 21745046
J Clin Pharmacol. 2004 Oct;44(10):1132-42
pubmed: 15342614
Clin Toxicol (Phila). 2007 Sep;45(6):662-77
pubmed: 17849242

Auteurs

Shintaro Shimozawa (S)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan. shin46260707@gmail.com.

Daisuke Usuda (D)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Toru Sasaki (T)

Clinical Training Center, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Shiho Tsuge (S)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Riki Sakurai (R)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Kenji Kawai (K)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Shun Matsubara (S)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Risa Tanaka (R)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Makoto Suzuki (M)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Yuta Hotchi (Y)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Shungo Tokunaga (S)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Ippei Osugi (I)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Risa Katou (R)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Sakurako Ito (S)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Suguru Asako (S)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Kentaro Mishima (K)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Akihiko Kondo (A)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Keiko Mizuno (K)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Hiroki Takami (H)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Takayuki Komatsu (T)

Department of Sports Medicine, Faculty of Medicine, Juntendo University, Bunkyo-city 113-8421, Tokyo, Japan.

Jiro Oba (J)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Tomohisa Nomura (T)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Manabu Sugita (M)

Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, Nerima-city 177-8521, Tokyo, Japan.

Classifications MeSH